|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||6,464.85 - 6,556.00|
|52-week range||5,782.00 - 8,020.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||39.07|
|Earnings date||24 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||7,085.56|
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Reckitt's cleaning products such as Lysol and Dettol have been top sellers during the COVID-19 pandemic and led the company to post record sales last year. Despite the global popularity of its disinfecting products and other products such as Nurofen pain relief medication and Durex condoms, "there is less recognition of the company behind those brands," Jo Osborn, vice president of internal communications and corporate brand, said in a statement. The new name "reflects the existing widespread usage of Reckitt and is clearer, simpler and more memorable," Osborn said.
British consumer goods company Reckitt Benckiser Group is considering selling its infant formula business in Greater China, in a deal that could value the business at more than $2 billion, two people with knowledge of the matter said. The group has hired Morgan Stanley to conduct a strategic review of its infant formula unit Mead Johnson in Greater China, the sources said, declining to comment as the information is confidential. They however cautioned no decision has been made and that business valuation could change due to the impact of COVID-19.